World's Best Scientists 2026 revealed!
Pär Stattin

Pär Stattin

Award Badge
Medicine
Sweden
2023

D-Index & Metrics

Medicine

D-Index
110
Citations
36148
World Ranking
5632
National Ranking
121

Pär Stattin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pär Stattin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 567 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pär Stattin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pär Stattin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 110 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Sweden Leader Award

Overview

Pär Stattin is affiliated with Uppsala University in Sweden and has contributed extensively to the field of medicine, with a primary focus on prostate cancer research. Their work encompasses studies on prostate cancer treatment, diagnosis, and broader oncological concerns within global cancer incidence and screening.

The scientist has a significant number of publications across various esteemed venues, including:

  • Scandinavian Journal of Urology (19 publications)
  • The Journal of Urology (12 publications)
  • PLoS ONE (9 publications)
  • European Urology (8 publications)
  • British Journal of Urology (7 publications)

Pär Stattin's research contributions cover several specialized fields, notably pulmonary and respiratory medicine, oncology, surgery, economics and econometrics, and statistics and probability.

  • Pulmonary and Respiratory Medicine
  • Oncology
  • Surgery
  • Economics and Econometrics
  • Statistics and Probability

The primary topics addressed by their work include prostate cancer treatment and research, prostate cancer diagnosis and treatment, global cancer incidence and screening, cancer related to lipids and metabolism, health systems and economic evaluations with quality of life considerations, bladder and urothelial cancer treatments, and cancer risks and factors.

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Global Cancer Incidence and Screening
  • Cancer, Lipids, and Metabolism
  • Health Systems, Economic Evaluations, Quality of Life
  • Bladder and Urothelial Cancer Treatments
  • Cancer Risks and Factors

Significant recent papers illustrating their research scope include:

  • "Epidemiology and Prevention of Prostate Cancer," 2021, European Urology Oncology
  • "Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study," 2022, European Urology
  • "Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis," 2022, International Journal of Epidemiology
  • "Prostate cancer polygenic risk score and prediction of lethal prostate cancer," 2022, npj Precision Oncology
  • "Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia," 2022, International Journal of Cancer

Pär Stattin's frequent coauthors reflect ongoing collaborative efforts within the research community and include:

  • Hans Garmo (73 joint publications)
  • Rolf Gedeborg (24 joint publications)
  • Johan Styrke (23 joint publications)
  • Marcus Westerberg (20 joint publications)
  • Ingela Franck Lissbrant (16 joint publications)

Best Publications

  • Cumulative Association of Five Genetic Variants with Prostate Cancer

    S. Lilly Zheng;Jielin Sun;Fredrik Wiklund;Shelly Smith

  • Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.

    Goodarz Danaei;Yuan Lu;Gitanjali M. Singh;Emily Carnahan

  • Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.

    Pentti Tuohimaa;Leena Tenkanen;Merja Ahonen;Sonja Lumme

  • Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival.

    Emma Hörnberg;Erik Bovinder Ylitalo;Sead Crnalic;Henrik Antti

  • Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival

    I F Lissbrant;P Stattin;P Wikstrom;J E Damber

  • Prospective study of hyperglycemia and cancer risk.

    Pär Stattin;Ove Björ;Pietro Ferrari;Annekatrin Lukanova;Annekatrin Lukanova

  • Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

    Pernilla Wikström;Pär Stattin;Ingela Franck-Lissbrant;Jan-Erik Damber

  • Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer

    Julius Gudmundsson;Patrick Sulem;Thorunn Rafnar;Jon T. Bergthorsson

  • Obesity and colon cancer: Does leptin provide a link?

    Pär Stattin;Annekatrin Lukanova;Carine Biessy;Stefan Söderberg

  • Plasma Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-Binding Proteins, and Prostate Cancer Risk: a Prospective Study

    Pär Stattin;Annika Bylund;Sabina Rinaldi;Carine Biessy

  • Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.

    Andrew W. Roddam;Naomi E. Allen;Paul Appleby;Timothy J. Key

  • Epidemiology and Prevention of Prostate Cancer.

    Giorgio Gandaglia;Riccardo Leni;Freddie Bray;Neil Fleshner

  • Two Genome-wide Association Studies of Aggressive Prostate Cancer Implicate Putative Prostate Tumor Suppressor Gene DAB2IP

    David Duggan;Siqun L. Zheng;Michele Knowlton;Debbie Benitez

  • Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study

    Pär Stattin;Erik Holmberg;Jan-Erik Johansson;Lars Holmberg

  • Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.

    Annekatrin Lukanova;Eva Lundin;Andrea Micheli;Alan Arslan

  • Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts.

    Tanja Stocks;Kilian Rapp;Tone Bjørge;Tone Bjørge;Jonas Manjer

  • Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0

    Mieke Van Hemelrijck;Annette Wigertz;Fredrik Sandin;Hans Garmo

  • Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer

    Sean O'Farrell;Hans Garmo;Lars Holmberg;Jan Adolfsson

  • Leptin is associated with increased prostate cancer risk : a nested case-referent study.

    Pär Stattin;Stefan Söderberg;Göran Hallmans;Annika Bylund

  • Comment on: Cumulative Association of Five Genetic Variants with Prostate Cancer

    S. L. Zheng;J. Sun;F. Wiklund;S. Smith

Frequent Co-Authors

Göran Hallmans
Göran Hallmans Umeå University
Lars Holmberg
Lars Holmberg King's College London
Anders Bergh
Anders Bergh Umeå University
Rudolf Kaaks
Rudolf Kaaks German Cancer Research Center
Mats Lambe
Mats Lambe Karolinska Institute
Anders Engeland
Anders Engeland Norwegian Institute of Public Health
Henrik Grönberg
Henrik Grönberg Karolinska Institute
Hans-Olov Adami
Hans-Olov Adami Karolinska Institute
Elio Riboli
Elio Riboli Imperial College London
Lars Egevad
Lars Egevad Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and accelerated pathways in the medical field can help you kickstart or advance your healthcare career. Many students are now seeking flexible educational options to balance work, family, and study. Online degree programs are opening up new possibilities, making it easier to gain qualifications without traditional barriers.

For those already working as registered nurses, rn to bsn no clinical hours programs provide an efficient way to earn a Bachelor of Science in Nursing entirely online, without additional clinical requirements. This pathway is ideal for licensed nurses wanting academic advancement on their own schedule.

Students seeking the highest level of practice in nursing may consider shortest dnp programs or easiest online dnp programs. These online Doctor of Nursing Practice routes can shorten time to completion and may offer more accessible admissions standards, catering to experienced professionals aiming to reach the top of their field.

For those just starting, lpn fast track program opportunities empower students to become practical nurses quickly through accelerated online coursework. No matter your background, online medical degrees deliver new career pathways tailored for modern life.

Best Scientists Citing Pär Stattin

Trending Scientists

Recently Published Articles